Podocyte Density and Albuminuria in Aging Diabetic Ins2± Mice with or Without Adenosine A1 Receptor Signaling

References

• Reutens AT, Atkins RC. Epidemiology of diabetic nephropathy. Contrib Nephrol. 2011;170:1–7.21659752
   PubMed Web of Science ®Google Scholar
• Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(Suppl 2):64–78. doi:10.2337/diab.32.2.S646400670
   PubMed Web of Science ®Google Scholar
• Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol. 2011;170:36–47.21659756
   PubMed Web of Science ®Google Scholar
• Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol. 2007;106(2):p26–p31. doi:10.1159/00010179717570945
   PubMed Web of Science ®Google Scholar
• Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13(12):3005–3015. doi:10.1097/01.ASN.0000039661.06947.FD12444221
   PubMed Web of Science ®Google Scholar
• Stitt-Cavanagh E, MacLeod L, Kennedy C. The podocyte in diabetic kidney disease. ScientificWorldJournal. 2009;9:1127–1139. doi:10.1100/tsw.2009.13319838599
   PubMed Web of Science ®Google Scholar
• Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006;55(1):225–233. doi:10.2337/diabetes.55.01.06.db05-089416380497
   PubMed Web of Science ®Google Scholar
• Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008;172(2):299–308. doi:10.2353/ajpath.2008.07005718202193
   PubMed Web of Science ®Google Scholar
• Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99(2):342–348. doi:10.1172/JCI1191639006003
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Iwano M, Suzuki D, et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis. 2009;54(4):653–664. doi:10.1053/j.ajkd.2009.05.00919615802
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4(1):39–45. doi:10.2174/15733990878350237018220694
   PubMedGoogle Scholar
• Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol. 2005;16(6):1733–1741. doi:10.1681/ASN.200502015915829708
   PubMed Web of Science ®Google Scholar
• Steffes MW, Schmidt D, McCrery R, Basgen JM. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001;59(6):2104–2113. doi:10.1046/j.1523-1755.2001.00725.x11380812
   PubMed Web of Science ®Google Scholar
• Teiken JM, Audettey JL, Laturnus DI, Zheng S, Epstein PN, Carlson EC. Podocyte loss in aging OVE26 diabetic mice. Anat Rec (Hoboken). 2008;291(1):114–121. doi:10.1002/ar.2062518085629
   PubMedGoogle Scholar
• Naito M, Fujikura J, Ebihara K, et al. Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes. 2011;60(9):2265–2273. doi:10.2337/db10-179521810600
   PubMed Web of Science ®Google Scholar
• Faulhaber-Walter R unpublished data. 2013.
   Google Scholar
• Faulhaber-Walter R, Jou W, Mizel D, et al. Impaired glucose tolerance in the absence of adenosine A1 receptor signaling. Diabetes. 2011;60(10):2578–2587. doi:10.2337/db11-005821831968
   PubMed Web of Science ®Google Scholar
• Faulhaber-Walter R, Chen L, Oppermann M, et al. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol. 2008;19(4):722–730. doi:10.1681/ASN.200706072118256360
   PubMed Web of Science ®Google Scholar
• Qi Z, Whitt I, Mehta A, et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol. 2004;286(3):F590–F596. doi:10.1152/ajprenal.00324.200314600035
   PubMed Web of Science ®Google Scholar
• Sanden SK, Wiggins JE, Goyal M, Riggs LK, Wiggins RC. Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with wilms’ tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol. 2003;14(10):2484–2493. doi:10.1097/01.ASN.0000089829.45296.7C14514726
   PubMed Web of Science ®Google Scholar
• Coward RJ, Welsh GI, Yang J, et al. The human glomerular podocyte is a novel target for insulin action. Diabetes. 2005;54(11):3095–3102. doi:10.2337/diabetes.54.11.309516249431
   PubMed Web of Science ®Google Scholar
• Stieger N, Worthmann K, Schiffer M. The role of metabolic and haemodynamic factors in podocyte injury in diabetes. Diabetes Metab Res Rev. 2011;27(3):207–215. doi:10.1002/dmrr.v27.321309047
   PubMed Web of Science ®Google Scholar
• Schiffer M, Park JK, Tossidou I, et al. Erythropoietin prevents diabetes-induced podocyte damage. Kidney Blood Press Res. 2008;31(6):411–415. doi:10.1159/00018636819096223
   PubMed Web of Science ®Google Scholar
• Fornoni A. Proteinuria, the podocyte, and insulin resistance. N Engl J Med. 2010;363(21):2068–2069. doi:10.1056/NEJMcibr100839521083394
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Kayo T, Ikeda T, Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes. 1997;46(5):887–894. doi:10.2337/diab.46.5.8879133560
   PubMed Web of Science ®Google Scholar
• Nakagawa T. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism. Clin Nephrol. 2009;71(2):103–109. doi:10.5414/CNP7110319203501
   PubMed Web of Science ®Google Scholar
• Kanetsuna Y, Takahashi K, Nagata M, et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol. 2007;170(5):1473–1484. doi:10.2353/ajpath.2007.06048117456755
   PubMed Web of Science ®Google Scholar
• Alpers CE, Hudkins KL. Mouse models of diabetic nephropathy. Curr Opin Nephrol Hypertens. 2011;20(3):278–284. doi:10.1097/MNH.0b013e328345190121422926
   PubMed Web of Science ®Google Scholar
• Hudkins KL, Pichaiwong W, Wietecha T, et al. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol. 2010;21(9):1533–1542. doi:10.1681/ASN.200912129020634301
   PubMed Web of Science ®Google Scholar
• Zheng S, Noonan WT, Metreveli NS, et al. Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes. 2004;53(12):3248–3257. doi:10.2337/diabetes.53.12.324815561957
   PubMed Web of Science ®Google Scholar